A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

The chip can simulate breathing and lung disease for an individual, holding promise for testing personalized treatments for tuberculosis.

Liver cells exposed to a high fat diet revert to an immature state that is more susceptible to cancer-causing mutations.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Samsung Biologics will acquire the Rockville assets for $280 million with closing anticipated toward the end of Q1 of 2026.

Use this brand-new eBook from Cytiva to learn more about the oligonucleotide market as a whole and about the full workflow solutions available today. We hope you enjoy it!

A new study shows how histones undergo correct chemical modifications during synthesis to guide new therapies.

New findings could aid future development of more efficient therapeutic strategies in the context of regenerative medicine and aging.

In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines ...

Study demonstrated that the Homer1 gene improves focus by reducing “noise” in the prefrontal cortex, with implications for studying attention disorders.

The documents in this eBook provide a glimpse of the kinds of questions asked and answered by researchers using the SomaScan Platform unmatched breakthrough technology.